Real-time enrollment status for this antisynthetase syndrome clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:50 AM UTC
| NCT Number | NCT07391605 |
| Recruiting Status | Recruiting |
| Condition | Antisynthetase Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Cartesian Therapeutics |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT07391605 is currently recruiting participants. This phase2 study for antisynthetase syndrome is actively seeking new participants at 4 locations across the United States. The study is sponsored by Cartesian Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07391605 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07391605 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.